These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35191968)

  • 21. Impact of an alcohol withdrawal syndrome practice guideline on surgical patient outcomes.
    Stanley KM; Amabile CM; Simpson KN; Couillard D; Norcross ED; Worrall CL
    Pharmacotherapy; 2003 Jul; 23(7):843-54. PubMed ID: 12885097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Phenobarbital in Alcohol Withdrawal Management - A Retrospective Comparison Study of Phenobarbital and Benzodiazepines for Acute Alcohol Withdrawal Management in General Medical Patients.
    Nisavic M; Nejad SH; Isenberg BM; Bajwa EK; Currier P; Wallace PM; Velmahos G; Wilens T
    Psychosomatics; 2019; 60(5):458-467. PubMed ID: 30876654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Gabapentin and Baclofen Combination for Inpatient Management of Alcohol Withdrawal Syndrome.
    Karapetyan K; Rosenfeldt Z; Caniff K
    Fed Pract; 2023 Apr; 40(4):128-133. PubMed ID: 37223663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service.
    Leung JG; Rakocevic DB; Allen ND; Handler EM; Perossa BA; Borreggine KL; Stark AL; Betcher HK; Hosker DK; Minton BA; Braus BR; Dierkhising RA; Philbrick KL
    Psychosomatics; 2018; 59(5):496-505. PubMed ID: 29735241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.
    Wong A; Benedict NJ; Armahizer MJ; Kane-Gill SL
    Ann Pharmacother; 2015 Jan; 49(1):14-9. PubMed ID: 25325907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients.
    Butterfield M; Thorne-Humphrey L; Suzuki J; Herschenhous N
    Am J Addict; 2020 Nov; 29(6):500-507. PubMed ID: 32490573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Dexmedetomidine as an Adjunct to Phenobarbital for Alcohol Withdrawal in Critically Ill Patients.
    Ware LR; Schuler BR; Goodberlet MZ; Marino KK; Lupi KE; DeGrado JR
    J Intensive Care Med; 2023 Jun; 38(6):553-561. PubMed ID: 36703284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges.
    Farrokh S; Roels C; Owusu KA; Nelson SE; Cook AM
    Neurocrit Care; 2021 Apr; 34(2):593-607. PubMed ID: 32794143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):E1-E2. PubMed ID: 29200055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective review and assessment of benzodiazepines in the treatment of alcohol withdrawal in hospitalized patients.
    Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1994; 14(5):572-8. PubMed ID: 7997390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexmedetomidine for Alcohol Withdrawal Syndrome.
    Linn DD; Loeser KC
    Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
    Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
    Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit.
    Oks M; Cleven KL; Healy L; Wei M; Narasimhan M; Mayo PH; Kohn N; Koenig S
    J Intensive Care Med; 2020 Sep; 35(9):844-850. PubMed ID: 29925291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):188-195. PubMed ID: 29200045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal.
    Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1994; 14(5):579-85. PubMed ID: 7997391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.